Svetlana Trestman

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma

Irit Avivi, Roi Balaban, Tamir Shragai et al. · British Journal of Haematology · 2021 · 77 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Rosiglitazone (PPARγ‐agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes–atherosclerosis mouse model

Zohar Levi, Aviv Shaish, Niva Yacov et al. · Diabetes Obesity and Metabolism · 2003 · 72 citations

Medicine, Endocrinology, Pharmacology +17

Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study

Tamir Shragai, Hila Magen, Noa Lavi et al. · British Journal of Haematology · 2022 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study

Yaël C. Cohen, Hila Magen, Noa Lavi et al. · Annals of Hematology · 2020 · 23 citations

Medicine, Oncology, Pharmacology +12